AI-Powered Sleep System Wins Design Award

The global sleep tech market was valued at over $29 billion in 2025 and is projected to grow to more than $153 billion by 2035. This growth is driven by increasing consumer awareness of sleep's impact on health and a rising prevalence of sleep disorders. Wearable devices currently dominate the market, accounting for over 75% of revenue in 2025. San Francisco-based Orion Sleep, founded in 2025, recently closed a $17.5 million seed round from investors including Mucker Capital and Browder Capital. The company was co-founded by Harry Gestetner, whose previous company Fanfix was acquired for a reported $65 million, and his father Daniel Gestetner, who co-founded Byte, which was acquired for over $1 billion. Orion's system competes in a dynamic market against players like Eight Sleep, Oura Health, and Sleep Number. These companies utilize a range of biometric sensors to track metrics like heart rate variability (HRV), respiratory rates, and movement to provide personalized insights. While wearables like the Oura ring use infrared LEDs, the Orion and Eight Sleep Pods embed sensors directly into a mattress cover to monitor biometrics. For consumer health apps, user acquisition strategies often focus on building trust through expert-driven content and leveraging user-generated content to foster a sense of community. A key challenge is overcoming user reluctance to share sensitive health data, a concern that has led to 43% of users deleting health apps after download due to the amount of personal information requested. Focusing on a strong retention strategy is crucial, as retaining a user can be five times cheaper than acquiring a new one. Navigating health data privacy is a critical concern for founders in this space. While many consumer wellness apps fall outside of HIPAA regulations, a patchwork of state laws like Washington's My Health My Data Act (MHMDA) and California's Confidentiality of Medical Information Act (CMIA) are creating stricter rules. These laws now require explicit "opt-in" consent before collecting or sharing consumer health data. Early-stage fundraising in digital health remains active, with investors prioritizing startups with clear revenue models and strong governance. Pre-seed and seed funding are often used to develop a minimum viable product (MVP) and gather initial user feedback, which is crucial in the capital-intensive health tech sector. Non-dilutive funding through grants and accelerators is also a common strategy for early-stage companies.